Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma
about
Immunodetection of nmt55/p54nrb isoforms in human breast cancerPSF is a novel corepressor that mediates its effect through Sin3A and the DNA binding domain of nuclear hormone receptorsHuman 100-kDa homologous DNA-pairing protein is the splicing factor PSF and promotes DNA strand invasionRegulation of the MiTF/TFE bHLH-LZ transcription factors through restricted spatial expression and alternative splicing of functional domainsHacking RNA: Hakai promotes tumorigenesis by enhancing the RNA-binding function of PSFCloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocationThe acute myeloid leukemia-associated protein, DEK, forms a splicing-dependent interaction with exon-product complexesPrimary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescentsThe metabolic basis of kidney cancerComprehensive molecular characterization of clear cell renal cell carcinoma.Integrated molecular analysis of clear-cell renal cell carcinoma.TFEB at a glancePSF and p54(nrb)/NonO--multi-functional nuclear proteinsNPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphoma.Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases.Gene expression profiling of alveolar soft-part sarcoma (ASPS).Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor-associated tumors: results of a multicenter phase 2 trial.Novel roles for the MiTF/TFE family of transcription factors in organelle biogenesis, nutrient sensing, and energy homeostasisNovel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma.Roles of PSF protein and VL30 RNA in reversible gene regulation.PRCC, the commonest TFE3 fusion partner in papillary renal carcinoma is associated with pre-mRNA splicing factors.Non-clear cell renal cancer: disease-based management and opportunities for targeted therapeutic approaches.Next-generation sequencing of translocation renal cell carcinoma reveals novel RNA splicing partners and frequent mutations of chromatin-remodeling genes.Alveolar soft-part sarcoma: a review and update.Alveolar soft part sarcomas: molecular pathogenesis and implications for novel targeted therapies.Subclassification of renal cell neoplasms: an update for the practising pathologist.Comprehensive exploration of novel chimeric transcripts in clear cell renal cell carcinomas using whole transcriptome analysisMonitoring microarray-based gene expression profile changes in hepatocellular carcinomaCompromised paraspeckle formation as a pathogenic factor in FUSopathies.The relevance of testing the efficacy of anti-angiogenesis treatments on cells derived from primary tumors: a new method for the personalized treatment of renal cell carcinoma.Hypoxia-induced transcriptional repression of the melanoma-associated oncogene MITF.TMED6-COG8 is a novel molecular marker of TFE3 translocation renal cell carcinoma.Molecular confirmation of t(6;11)(p21;q12) renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrumPathological and molecular biological aspects of the renal epithelial neoplasms, up-to-date.Unique patterns of allelic imbalance distinguish type 1 from type 2 sporadic papillary renal cell carcinomaMolecular genetics and cellular features of TFE3 and TFEB fusion kidney cancersValidation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.Newly designed break-apart and ASPL-TFE3 dual-fusion FISH assay are useful in diagnosing Xp11.2 translocation renal cell carcinoma and ASPL-TFE3 renal cell carcinoma: a STARD-compliant articleXp11 translocation renal cell carcinoma (RCC): extended immunohistochemical profile emphasizing novel RCC markers.Biochemical and molecular markers in renal cell carcinoma: an update and future prospects.
P2860
Q21261337-8E23AE8E-7E48-40D5-8BC2-179AE6504B93Q24290950-605220E9-6E74-456E-91C3-7D48A19C9AA3Q24522742-D915651C-651B-4F01-A79F-E2737977BE7FQ24562758-11213748-F0CB-4155-9C6F-0B4C017EF0D8Q24645018-6B22504E-E861-4406-AEE9-B54827F3CF95Q24675000-1E45CA60-3195-4EF0-8925-81B8790667B3Q24684940-F752E76F-66C7-4683-ADDA-3DE5BB7151BDQ24685802-9A0EDDA2-4526-4CE5-8112-D0E0427FA508Q27023273-676497D6-C6BE-49AE-B029-AC64992C61F7Q27852374-A38A0B16-29E6-4E8E-9DA7-2B01E868AF30Q27852382-906222FB-3F17-4304-9E9F-CF680EB27C26Q28074375-1796F579-F866-4824-AAF3-DD84776D4DBCQ28213410-C04A5935-B051-4903-B9D7-88A691356E61Q30831857-43259CAC-D44B-471D-900F-BA70538149DAQ33274854-201B03F6-90E5-4A27-A283-1C61D5939B80Q33400116-B7C0BEE1-E159-453D-B5BC-43694FEB4934Q33401272-A2CC68E1-E0DC-4E08-AEFE-39B63A10352CQ33756641-B8363D48-11AF-4852-BAB3-8BF9AFBCF4D4Q33874474-A7E3CC49-3443-4D50-B64B-0C4FA227A800Q33922917-53FE6F99-5E38-4C1C-9D21-EDD97EE2D552Q33943447-C58B1D97-068F-4D4A-8FB9-9BC2CA84059BQ34194075-41B99558-EF0E-4453-97E9-06FA5A4A0343Q34206517-AACC6D54-1AEA-4903-BFA2-65A05F256D61Q34572170-DC1930FB-A4EF-4A68-841E-731DF95BB92FQ34638089-833B3136-D3DB-47EB-A4DB-46CD414BC079Q34969974-D1F12CF4-8087-48A9-9431-9E9D31E55630Q35005701-23C0EB74-84E1-4490-82C3-18DA240D3724Q35011295-8CBE64F0-45B8-4A43-B6F4-A1A2DCB7B699Q35066217-96D8E970-F4B2-428A-BFD0-FFD43C0546F6Q35133904-977CF317-E84E-4979-8358-A245251279FFQ35470449-68ED57CC-6320-411D-A87A-81951911B772Q35632133-95483698-7CD7-421B-A65F-F54550B734E9Q35636323-E8C33D13-C6E2-499E-8D5A-169517B6B6E1Q35773595-9283C118-2B0E-4C87-8B47-786A97F408A5Q35789042-69E64E3E-EB3D-458D-89D4-ACE5E56D5B29Q36001179-C7978108-0522-43B2-A3C1-DC92D88ABA67Q36104776-1B358281-5827-4013-B393-25B1CAEEB7A7Q36151526-1F5CA737-B3D4-40B9-84FA-591FC343A191Q36253663-9409BA02-5728-4BD1-AD23-2A2A11B963DEQ36271231-57F402F2-926C-40DF-9177-FC0C79860BE1
P2860
Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma
description
1997 nî lūn-bûn
@nan
1997 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Fusion of splicing factor gene ...... papillary renal cell carcinoma
@ast
Fusion of splicing factor gene ...... papillary renal cell carcinoma
@en
Fusion of splicing factor gene ...... papillary renal cell carcinoma
@nl
type
label
Fusion of splicing factor gene ...... papillary renal cell carcinoma
@ast
Fusion of splicing factor gene ...... papillary renal cell carcinoma
@en
Fusion of splicing factor gene ...... papillary renal cell carcinoma
@nl
prefLabel
Fusion of splicing factor gene ...... papillary renal cell carcinoma
@ast
Fusion of splicing factor gene ...... papillary renal cell carcinoma
@en
Fusion of splicing factor gene ...... papillary renal cell carcinoma
@nl
P2093
P4510
P3181
P356
P1433
P1476
Fusion of splicing factor gene ...... papillary renal cell carcinoma
@en
P2093
C S Cooper
S K Sidhar
W M Linehan
P2888
P304
P3181
P356
10.1038/SJ.ONC.1201394
P407
P577
1997-10-01T00:00:00Z
P5875
P6179
1044829641